Picture of Pliant Therapeutics logo

PLRX — Pliant Therapeutics News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareAdventurousMicro CapNeutral

Brief: Pliant Therapeutics Announces FDA Clearance Of Investigational NDA For PLN-101095

Feb 2 (Reuters) - Pliant Therapeutics Inc  PLRX.O :
    * PLIANT THERAPEUTICS ANNOUNCES FDA CLEARANCE OF
INVESTIGATIONAL
NEW DRUG APPLICATION FOR PLN-101095, A NOVEL INTEGRIN INHIBITOR
FOR THE TREATMENT OF SOLID TUMORS

Source text for Eikon:  ID:nGNX9pLXRG 
Further company coverage:  PLRX.O 
 ((Reuters.Briefs@thomsonreuters.com;))

Recent news on Pliant Therapeutics

See all news